000			02044 a2200517 4500
005			20250516190534.0
264		0	_c20140416
008			201404s 0 0 eng d
022			_a0006-3002
024	7		_a10.1016/j.bbagrm.2013.12.004 _2doi
040			_aNLM _beng _cNLM
100	1		_aShimoyama, Shuji
245	0	0	_aDephosphorylation of Sp1 at Ser-59 by protein phosphatase 2A (PP2A) is required for induction of CYP1A1 transcription after treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin or omeprazole. _h[electronic resource]
260			_bBiochimica et biophysica acta _cFeb 2014
300			_a107-15 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aBlotting, Western
650	0	4	_aCaco-2 Cells
650	0	4	_aChelating Agents _xpharmacology
650	0	4	_aCytochrome P-450 CYP1A1 _xgenetics
650	0	4	_aEgtazic Acid _xanalogs & derivatives
650	0	4	_aEnzyme Inhibitors _xpharmacology
650	0	4	_aHep G2 Cells
650	0	4	_aHumans
650	0	4	_aMCF-7 Cells
650	0	4	_aModels, Genetic
650	0	4	_aOkadaic Acid _xpharmacology
650	0	4	_aOmeprazole _xpharmacology
650	0	4	_aPhosphorylation _xdrug effects
650	0	4	_aPolychlorinated Dibenzodioxins _xpharmacology
650	0	4	_aPromoter Regions, Genetic _xgenetics
650	0	4	_aProtein Binding
650	0	4	_aProtein Phosphatase 2 _xantagonists & inhibitors
650	0	4	_aProton Pump Inhibitors _xpharmacology
650	0	4	_aRNA Interference
650	0	4	_aReceptors, Aryl Hydrocarbon _xgenetics
650	0	4	_aReverse Transcriptase Polymerase Chain Reaction
650	0	4	_aSerine _xmetabolism
650	0	4	_aSp1 Transcription Factor _xmetabolism
650	0	4	_aTranscriptional Activation _xdrug effects
700	1		_aKasai, Shuya
700	1		_aKahn-Perlès, Brigitte
700	1		_aKikuchi, Hideaki
773	0		_tBiochimica et biophysica acta _gvol. 1839 _gno. 2 _gp. 107-15
856	4	0	_uhttps://doi.org/10.1016/j.bbagrm.2013.12.004 _zAvailable from publisher's website
999			_c23409276 _d23409276